Gain Therapeutics, Inc. announced a private placement of 2,500,088 shares of common stock at a price of $2 per share and pre funded warrants at a price of $2 per share for the gross proceeds of $5,000,176 on November 20, 2023. The warrants will be exercisable into 2,500,088 shares of common stock at an exercise price of $2.75 per share. The transaction is expected to close on November 24, 2023.